{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:58:42Z","timestamp":1792886322516,"version":"4.5.0"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>Drug\u2013drug interactions (DDIs) can result in patient harm. DDI alerts are intended to help prevent harm; when the majority of alerts presented to providers are being overridden, their value is diminished. Our objective was to evaluate the overall rates of DDI alert overrides and how rates varied by specialty, clinician type, and patient complexity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>A retrospective study of DDI alert overrides that occurred during 2012 and 2013 within the inpatient setting described at the medication-, hospital-, provider-, and patient encounter\u2013specific levels was performed at an urban, quaternary-care, pediatric hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>There were &amp;gt;41\u2009000 DDI alerts presented to clinicians; \u223c90% were overridden. The 5 DDI pairs that were most frequently presented and overridden included the following: potassium chloride\u2013spironolactone, methadone\u2013ondansetron, ketorolac\u2013ibuprofen, cyclosporine\u2013fluconazole, and potassium chloride\u2013enalapril, each with an alert override rate of \u22650.89. Override rates across provider groups ranged between 0.84 and 0.97. In general, patients with high complexity had a higher frequency of alert overrides, but the rates of alert overrides for each DDI pairing did not differ significantly.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>High rates of DDI alert overrides occur across medications, provider groups, and patient encounters. Methods to decrease DDI alerts which are likely to be overridden exist, but it is also clear that more robust and intelligent tools are needed. Characteristics exist at the medication, hospital, provider, and patient levels that can be used to help specialize and enhance information transmission.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2017-0124","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T08:30:26Z","timestamp":1525163426000},"page":"293-299","source":"Crossref","is-referenced-by-count":16,"title":["An Investigation of Drug\u2013Drug Interaction Alert Overrides at a Pediatric Hospital"],"prefix":"10.1542","volume":"8","author":[{"given":"Kate","family":"Humphrey","sequence":"first","affiliation":[{"name":"Divisions of General Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jorina","sequence":"additional","affiliation":[{"name":"Center for Applied Pediatric Quality Analytics, Boston Children\u2019s Hospital, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Harper","sequence":"additional","affiliation":[{"name":"Emergency Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Dodson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Athenahealth, Watertown, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Ozonoff","sequence":"additional","affiliation":[{"name":"Center for Applied Pediatric Quality Analytics, Boston Children\u2019s Hospital, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"issue":"16","key":"2021120817292296200_B1","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"2021120817292296200_B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00148581-200911020-00005","article-title":"Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study","volume":"11","author":"Kunac","year":"2009","journal-title":"Paediatr Drugs"},{"key":"2021120817292296200_B3","volume-title":"Health IT and Patient Safety: Building Safer Systems for Better Care","author":"Institute of Medicine","year":"2012"},{"issue":"1","key":"2021120817292296200_B4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1470-2045(10)70105-4","article-title":"Drug interactions in childhood cancer","volume":"12","author":"Haidar","year":"2011","journal-title":"Lancet Oncol"},{"key":"2021120817292296200_B5","volume-title":"Goodman and Gilman\u2019s: The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011","edition":"12th ed."},{"issue":"1","key":"2021120817292296200_B6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2015","article-title":"Potential drug-drug interactions in infant, child, and adolescent patients in children\u2019s hospitals","volume":"135","author":"Feinstein","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"2021120817292296200_B7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40264-015-0303-y","article-title":"Preventability of voluntarily reported or trigger tool-identified medication errors in a pediatric institution by information technology: a retrospective cohort study","volume":"38","author":"Stultz","year":"2015","journal-title":"Drug Saf"},{"issue":"3","key":"2021120817292296200_B8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4338\/ACI-2013-12-RA-0103","article-title":"Drug interaction alert override rates in the meaningful use era: no evidence of progress","volume":"5","author":"Bryant","year":"2014","journal-title":"Appl Clin Inform"},{"issue":"21","key":"2021120817292296200_B9","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1001\/archinte.163.21.2625","article-title":"Physicians\u2019 decisions to override computerized drug alerts in primary care","volume":"163","author":"Weingart","year":"2003","journal-title":"Arch Intern Med"},{"issue":"3","key":"2021120817292296200_B10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jamia\/ocv143","article-title":"Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience","volume":"23","author":"Topaz","year":"2016","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"2021120817292296200_B11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/amiajnl-2013-001813","article-title":"Overrides of medication-related clinical decision support alerts in outpatients","volume":"21","author":"Nanji","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2021120817292296200_B12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cmpb.2013.02.006","article-title":"Physicians\u2019 responses to computerized drug-drug interaction alerts for outpatients","volume":"111","author":"Yeh","year":"2013","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"2021120817292296200_B13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"van der Sijs","year":"2006","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2021120817292296200_B14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PTS.0000000000000050","article-title":"Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry","volume":"10","author":"Harper","year":"2014","journal-title":"J Patient Saf"},{"issue":"6","key":"2021120817292296200_B15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/jamia\/ocv011","article-title":"Recommendations to improve the usability of drug-drug interaction clinical decision support alerts","volume":"22","author":"Payne","year":"2015","journal-title":"J Am Med Inform Assoc"},{"key":"2021120817292296200_B16","volume-title":"Multum [Internet]"},{"issue":"2","key":"2021120817292296200_B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PTS.0b013e31821d6f6e","article-title":"Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches","volume":"7","author":"Classen","year":"2011","journal-title":"J Patient Saf"},{"key":"2021120817292296200_B18","unstructured":"Cerner Knowledge Sharing Platform. Alert severity levels in powerorders. Available at: https:\/\/wiki.ucern.com\/display\/public\/1101powerordersHP\/Alert+Severity+Levels+in+PowerOrders. Accessed November 30, 2016"},{"issue":"4","key":"2021120817292296200_B19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.2004-0650","article-title":"Clinical redesign using all patient refined diagnosis related groups","volume":"114","author":"Sedman","year":"2004","journal-title":"Pediatrics"},{"issue":"9","key":"2021120817292296200_B20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijmedinf.2015.04.006","article-title":"The effect of provider characteristics on the responses to medication-related decision support alerts","volume":"84","author":"Cho","year":"2015","journal-title":"Int J Med Inform"},{"key":"2021120817292296200_B21","first-page":"339","article-title":"A successful model and visual design for creating context-aware drug-drug interaction alerts","volume-title":"AMIA Annu Symp Proc","author":"Duke","year":"2011"},{"issue":"1","key":"2021120817292296200_B22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1472-6947-13-65","article-title":"Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records","volume":"13","author":"Phansalkar","year":"2013","journal-title":"BMC Med Inform Decis Mak"},{"issue":"5","key":"2021120817292296200_B23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00228-011-1183-4","article-title":"Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study","volume":"68","author":"Rashed","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2021120817292296200_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archpediatrics.2011.161","article-title":"Prevalence of polypharmacy exposure among hospitalized children in the United States","volume":"166","author":"Feudtner","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021120817292296200_B25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1741-7015-11-237","article-title":"Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions","volume":"11","author":"Thiesen","year":"2013","journal-title":"BMC Med"},{"key":"2021120817292296200_B26","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/jamia\/ocv144","article-title":"Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts","volume":"23","author":"McDaniel","year":"2016","journal-title":"J Am Med Inform Assoc"},{"issue":"16","key":"2021120817292296200_B27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/archinternmed.2009.252","article-title":"An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care","volume":"169","author":"Weingart","year":"2009","journal-title":"Arch Intern Med"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/8\/5\/293\/814912\/hpeds_2017-0124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/8\/5\/293\/814912\/hpeds_2017-0124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T18:04:42Z","timestamp":1638986682000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/8\/5\/293\/26604\/An-Investigation-of-Drug-Drug-Interaction-Alert"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2017-0124","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}